pyrimidine has been researched along with r 121919 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bozigian, H; Chen, C; Chen, TK; Grigoriadis, DE; Huang, CQ; Liu, XJ; McCarthy, JR; Saunders, J; Webb, TR; Wilcoxen, KM; Xie, YF; Zhu, YF | 1 |
1 other study(ies) available for pyrimidine and r 121919
Article | Year |
---|---|
Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]pyrimidine (NBI 30775/R121919) and structure--activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonists.
Topics: Adrenocorticotropic Hormone; Animals; Corticotropin-Releasing Hormone; Cyclic AMP; Drug Design; Inhibitory Concentration 50; Male; Mice; Molecular Structure; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Structure-Activity Relationship | 2004 |